The Management of Noonan Syndrome From Early Diagnosis To Optimal Therapeutic Response to Growth Hormone

The Management of Noonan Syndrome From Early Diagnosis To Optimal Therapeutic Response to Growth Hormone is organized by Springer Healthcare IME.

Learning Objectives:
After participating in the webinar, learners will be able to:
• Demonstrate awareness of Noonan syndrome
• Explain the clinical burden of Noonan syndrome and related disorders in the untreated state
• Apply Sanger and genetic sequencing in the early diagnosis of Noonan syndrome
• Interpret clinical trial data and evidence (from outside of Europe) showing the impact of growth hormone therapy on improvement in clinical outcomes in short stature in patients diagnosed with Noonan syndrome

Additional details will be posted as soon as information is available.